The European Commission (EC) has granted approval to Illumina's divestment plan for cancer test-maker Grail, aligning with the EU Merger Regulation. This follows the Commission's directive from ...
Biotechnology company Illumina has announced the completion of its spin-off of cancer test-maker Grail, which is now an ...
Much of Icahn's opposition stemmed from Illumina's decision to close the acquisition without gaining approval from antitrust regulators in the EU and U.S ... a cost-cutting plan designed to ...
European Union countries on Monday gave final approval ... plan to better protect nature in the 27-nation bloc, a divisive issue after months of protests by farmers who argued that EU ...
GRAIL shares started trading on Nasdaq after a spin-off from Illumina, as the EU's regulatory ... still behind MCED legislation, FDA approval, and medical plan reimbursement implementation.
After years of negotiations, the European Parliament has approved a major reform tightening the EU's migration and asylum rules. The EU Asylum and Migration Pact has been in the works since 2015.
European Union lawmakers approved an increase ... has made to target EU cars and car parts. The European Parliament voted by 457-140, with 71 abstentions, in favor of a plan to allow U.S. farmers ...
The aid from the Dutch and French governments was initially approved in 2020 but the EU's General Court subsequently annulled it twice following a complaint by Ryanair (RYA.I) , opens new tab.
After more than six months, the EU Commission on Monday evening approved the fourth disbursement of €923 million under Slovakia’s recovery plan. After pre-financing deductions, Slovakia is ...
Despite letting go of Grail last month, Illumina isn’t shying away from M&A. The DNA sequencing giant has now acquired Fluent BioSciences to expand its reach in single-cell analysis and ...
NATO Approves a Plan to Speed Security Aid and Training to ... Moscow has taken advantage of a lengthy delay in U.S. military aid. EU funds were also held up by political infighting.
In April 2024, the European Commission approved Illumina's divestment plan for Grail, in accordance with the EU Merger Regulation. This decision aligns with the Commission's directive from October ...